Persistent dystonia induced by fluoxetine

Internal Medicine Journal

Volumn 38, Issue 8, 2008, Pages 672-674

  Bilen, S ^a,b   Saka, M ^a   Ak, F ^a   Oztekin N ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Botulinum toxin; Dystonia; Fluoxetine

Indexed keywords

BIPERIDEN; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUOXETINE; HALOPERIDOL; NORADRENALIN UPTAKE INHIBITOR; OPIPRAMOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; BRUXISM; CASE REPORT; DEPRESSION; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LOW DRUG DOSE; MALE; MENTAL DISEASE; MUSCLE SPASM; NECK MUSCLE; PATIENT COUNSELING; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXINS, TYPE A; DYSTONIA; FLUOXETINE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 51349109250     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01747.x     Document Type: Article

References (10)

1. Dominguez-Moran JA, Callejo JM, Fernandez-Ruiz LC, Martinez-Castrillo JC. Acute paroxysmal dystonia induced by fluoxetine. Mov Disord 2001 16 : 767 9.
2. Caley CF. Extrapyramidal reactions and selective serotonin-reuptake inhibitors. Ann Pharmacother 1997 31 : 1481 9.
3. Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 1998 12 : 192 214.
4. Aydin M, Hatirnaz O, Erensoy N, Ozbek U. CYP2D6 and CYP1A1 mutations in the Turkish population. Cell Biochem Funct 2005 23 : 133 5.
5. Diler RS, Yolga A, Avci A. Fluoxetine-induced extrapyramidal symptoms in an adolescent: a case report. Swiss Med Wkly 2002 132 : 125 6.
6. Chen JJ, Swope DM. A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A. J Clin Psychiatry 2005 66 : 267 8.
7. Dave M. Fluoxetine-associated dystonia. Am J Psychiatry 1994 151 : 149.
8. Pavlovic ZM. Buspirone to improve compliance in venlafaxine-induced movement disorder. Int J Neuropsychopharmacol 2004 7 : 523 4.
9. Reccoppa L, Welch WA, Ware MR. Acute dystonia and fluoxetine. J Clin Psychiatry 1990 51 : 487.
10. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996 57 : 449 54.